Does ZANUBRUTINIB Cause Myelosuppression? 147 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Myelosuppression have been filed in association with ZANUBRUTINIB (BRUKINSA). This represents 5.3% of all adverse event reports for ZANUBRUTINIB.
147
Reports of Myelosuppression with ZANUBRUTINIB
5.3%
of all ZANUBRUTINIB reports
4
Deaths
68
Hospitalizations
How Dangerous Is Myelosuppression From ZANUBRUTINIB?
Of the 147 reports, 4 (2.7%) resulted in death, 68 (46.3%) required hospitalization, and 14 (9.5%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZANUBRUTINIB. However, 147 reports have been filed with the FAERS database.
What Other Side Effects Does ZANUBRUTINIB Cause?
Off label use (376)
Disease progression (224)
Contusion (165)
Fatigue (146)
Rash (134)
Death (120)
White blood cell count decreased (119)
Platelet count decreased (112)
Anaemia (102)
Diarrhoea (101)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which ZANUBRUTINIB Alternatives Have Lower Myelosuppression Risk?
ZANUBRUTINIB vs ZAVEGEPANT
ZANUBRUTINIB vs ZEAXANTHIN
ZANUBRUTINIB vs ZELBORAF
ZANUBRUTINIB vs ZEMPLAR
ZANUBRUTINIB vs ZENATANE